Consultants  /  Dr. Anoop. P
Pediatric Oncologist consultant profile

Dr. Anoop. P

Senior Consultant

Apollo Hospital, Bangalore →

Pediatric OncologistImmunotherapy Radioimmunotherapy in Lymphoma Radiopeptide Therapy Clinical Application of Mesenchymal Stem Cells in Regenerative Medicine Cellular Therapy.
Request a written opinion Ask a care coordinator
Professional overview

About Dr. Anoop. P

  • Dr. Anoop. P is an eminent Pediatric Hematologist and has experience of more than 15 years.
  • His expertise lies in Blood disorders in adults & children and Solid- organ cancers in children.
  • He has a membership association with the Indian Academy of Pediatrics (IAP), British Society for Hematology (BSH), Royal College of Pediatrics& Child Health (RCPCH), Royal College of Pathologists (RCPath) and European Hematology Association (EHA). He has presented topics at recent scientific meetings on lymphoma (Lugano, Switzerland), leukemia (London, UK), stem cell mobilization (Baltimore, USA), autoimmune hemolytic anemia (Guildford, UK) and clinical trials (Oslo, Norway).
  • Dr. Anoop has publications in international as well as in national medical journals.
Clinical focus

Areas of expertise

Immunotherapy Radioimmunotherapy in Lymphoma Radiopeptide Therapy Clinical Application of Mesenchymal Stem Cells in Regenerative Medicine Cellular Therapy.

Training and experience

Qualifications

  • MBBS
  • MD
Research

Publications

  • Cruikshank M, Anoop P, Nikolajeva O, Rao A, Rao K, Gilmour K, Eleftheriou D, Brogan PA. Screening assays for primary hemophagocytic lymphohistiocytosis (HLH) in children presenting with suspected macrophage activation syndrome. Pediatr Rheumatol. 2015 Nov 16;13(48):1-9.
  • Anoop P, Roohi S. Acquired alpha thalassemia associated with erythroleukemia (AML M6). Am J Hematol. 2014 Jan;89(1):114-115.
  • Anoop P. Immune thrombocytopenic purpura (ITP): historical perspective, current status, recent advances and future directions. Indian Pediatr. 2012 Oct;49(10):811-818.
  • Anoop P, Sankpal S, Stiller C, Tewari S, Lancaster DL, Khabra K, Taj MM. Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma (B-NHL) and acute lymphoblastic leukemia (B-ALL). Leuk Lymphoma. 2012 Oct;53(10):1882-1888.
  • Anoop P, Lancaster DL, Rassam SM, Atra A. Florid erythroid dysplasia mimicking congenital dyserythropoietic anemia during the preleukemic phase of acute erythroleukemia. Pediatr Hematol Oncol. 2012 Mar;29(2):173-175.
  • Anoop P, Atra A. Prominent megakaryocytic dysplasia after regression of transient abnormal myelopoiesis associated with GATA-1 mutation. J Pediatr Hematol Oncol. 2012 Nov;34(8):640-641.
  • Anjay MA, Sasidharan CK, Anoop P. Hepatic subcapsular hematoma: two neonates with disparate presentations. Pediatr Neonatol. 2012 Apr;53(2):144-146.
  • Anoop P, Shaw BE, Riley U, Ethell ME, Taj M, Lancaster DL, Atra A, Saso R, Littlewood S, Mohammed K, Davies F, Treleaven J, Morgan GJ, Potter MN. Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis. Hematology. 2011 Jul;16(4):213-220.
  • Islam MS, Anoop P. Current concepts in the management of stroke in children with sickle cell disease. Childs Nerv Syst. 2011 Jul;27(7):1037-1043.
  • Anoop P, Riley U, Ethell ME, Treleaven J, Johnson EM, Morgan GJ, Potter MN. First report of fatal human infections with the cactophilic yeast Sporopachydermia cereana. J Infect. 2011 Apr;62(4):311-313.
Need help deciding?

Request coordinated guidance for your case.

Share your reports to understand suitable consultants, hospitals and next steps.

Request guidance →